The global Infectious Disease Diagnostics market size was valued at US$ 3564.7 million in 2023. With growing demand in downstream market, the Infectious Disease Diagnostics is forecast to a readjusted size of US$ 4838.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Infectious Disease Diagnostics market. Infectious Disease Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Disease Diagnostics. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Disease Diagnostics market.
Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
Key Features:
The report on Infectious Disease Diagnostics market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Infectious Disease Diagnostics market. It may include historical data, market segmentation by Type (e.g., Molecular Diagnostic Technique, Traditional Diagnostic Technique), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Disease Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Disease Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infectious Disease Diagnostics industry. This include advancements in Infectious Disease Diagnostics technology, Infectious Disease Diagnostics new entrants, Infectious Disease Diagnostics new investment, and other innovations that are shaping the future of Infectious Disease Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Disease Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Disease Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Disease Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Disease Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Disease Diagnostics market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Disease Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Disease Diagnostics market.
麻豆原创 Segmentation:
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Molecular Diagnostic Technique
Traditional Diagnostic Technique
Segmentation by application
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio M茅rieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Infectious Disease Diagnostics 麻豆原创 Size 2019-2030
2.1.2 Infectious Disease Diagnostics 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infectious Disease Diagnostics Segment by Type
2.2.1 Molecular Diagnostic Technique
2.2.2 Traditional Diagnostic Technique
2.3 Infectious Disease Diagnostics 麻豆原创 Size by Type
2.3.1 Infectious Disease Diagnostics 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infectious Disease Diagnostics 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Infectious Disease Diagnostics Segment by Application
2.4.1 Hepatitis C
2.4.2 Hepatitis B
2.4.3 Tuberculosis (TB)
2.4.4 Acquired Immunodeficiency Syndrome (AIDS)
2.4.5 Human Papillomavirus (HPV)
2.4.6 Methicillin-resistant Staphylococcus Aureus (MRSA)
2.5 Infectious Disease Diagnostics 麻豆原创 Size by Application
2.5.1 Infectious Disease Diagnostics 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infectious Disease Diagnostics 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Infectious Disease Diagnostics 麻豆原创 Size by Player
3.1 Infectious Disease Diagnostics 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Infectious Disease Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Infectious Disease Diagnostics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease Diagnostics by Regions
4.1 Infectious Disease Diagnostics 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Infectious Disease Diagnostics 麻豆原创 Size Growth (2019-2024)
4.3 APAC Infectious Disease Diagnostics 麻豆原创 Size Growth (2019-2024)
4.4 Europe Infectious Disease Diagnostics 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Infectious Disease Diagnostics 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Infectious Disease Diagnostics 麻豆原创 Size by Country (2019-2024)
5.2 Americas Infectious Disease Diagnostics 麻豆原创 Size by Type (2019-2024)
5.3 Americas Infectious Disease Diagnostics 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Diagnostics 麻豆原创 Size by Region (2019-2024)
6.2 APAC Infectious Disease Diagnostics 麻豆原创 Size by Type (2019-2024)
6.3 APAC Infectious Disease Diagnostics 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Disease Diagnostics by Country (2019-2024)
7.2 Europe Infectious Disease Diagnostics 麻豆原创 Size by Type (2019-2024)
7.3 Europe Infectious Disease Diagnostics 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Infectious Disease Diagnostics 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Infectious Disease Diagnostics 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Infectious Disease Diagnostics 麻豆原创 Forecast
10.1 Global Infectious Disease Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Infectious Disease Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Infectious Disease Diagnostics Forecast
10.1.3 APAC Infectious Disease Diagnostics Forecast
10.1.4 Europe Infectious Disease Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Disease Diagnostics Forecast
10.2 Americas Infectious Disease Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Infectious Disease Diagnostics 麻豆原创 Forecast
10.2.2 Canada Infectious Disease Diagnostics 麻豆原创 Forecast
10.2.3 Mexico Infectious Disease Diagnostics 麻豆原创 Forecast
10.2.4 Brazil Infectious Disease Diagnostics 麻豆原创 Forecast
10.3 APAC Infectious Disease Diagnostics Forecast by Region (2025-2030)
10.3.1 China Infectious Disease Diagnostics 麻豆原创 Forecast
10.3.2 Japan Infectious Disease Diagnostics 麻豆原创 Forecast
10.3.3 Korea Infectious Disease Diagnostics 麻豆原创 Forecast
10.3.4 Southeast Asia Infectious Disease Diagnostics 麻豆原创 Forecast
10.3.5 India Infectious Disease Diagnostics 麻豆原创 Forecast
10.3.6 Australia Infectious Disease Diagnostics 麻豆原创 Forecast
10.4 Europe Infectious Disease Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Infectious Disease Diagnostics 麻豆原创 Forecast
10.4.2 France Infectious Disease Diagnostics 麻豆原创 Forecast
10.4.3 UK Infectious Disease Diagnostics 麻豆原创 Forecast
10.4.4 Italy Infectious Disease Diagnostics 麻豆原创 Forecast
10.4.5 Russia Infectious Disease Diagnostics 麻豆原创 Forecast
10.5 Middle East & Africa Infectious Disease Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Infectious Disease Diagnostics 麻豆原创 Forecast
10.5.2 South Africa Infectious Disease Diagnostics 麻豆原创 Forecast
10.5.3 Israel Infectious Disease Diagnostics 麻豆原创 Forecast
10.5.4 Turkey Infectious Disease Diagnostics 麻豆原创 Forecast
10.5.5 GCC Countries Infectious Disease Diagnostics 麻豆原创 Forecast
10.6 Global Infectious Disease Diagnostics Forecast by Type (2025-2030)
10.7 Global Infectious Disease Diagnostics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bio M茅rieux SA
11.1.1 Bio M茅rieux SA Company Information
11.1.2 Bio M茅rieux SA Infectious Disease Diagnostics Product Offered
11.1.3 Bio M茅rieux SA Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Bio M茅rieux SA Main Business Overview
11.1.5 Bio M茅rieux SA Latest Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Information
11.2.2 Roche Diagnostics Infectious Disease Diagnostics Product Offered
11.2.3 Roche Diagnostics Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Roche Diagnostics Main Business Overview
11.2.5 Roche Diagnostics Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Infectious Disease Diagnostics Product Offered
11.3.3 Abbott Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 Thermo Fischer Scientific
11.4.1 Thermo Fischer Scientific Company Information
11.4.2 Thermo Fischer Scientific Infectious Disease Diagnostics Product Offered
11.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Thermo Fischer Scientific Main Business Overview
11.4.5 Thermo Fischer Scientific Latest Developments
11.5 BD
11.5.1 BD Company Information
11.5.2 BD Infectious Disease Diagnostics Product Offered
11.5.3 BD Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 BD Main Business Overview
11.5.5 BD Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Infectious Disease Diagnostics Product Offered
11.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Infectious Disease Diagnostics Product Offered
11.7.3 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Danaher
11.8.1 Danaher Company Information
11.8.2 Danaher Infectious Disease Diagnostics Product Offered
11.8.3 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Danaher Main Business Overview
11.8.5 Danaher Latest Developments
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Information
11.9.2 Johnson and Johnson Infectious Disease Diagnostics Product Offered
11.9.3 Johnson and Johnson Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Johnson and Johnson Main Business Overview
11.9.5 Johnson and Johnson Latest Developments
11.10 Guangzhou Wondfo Biotech Co.,Ltd.
11.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
11.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview
11.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
11.11 Getein Biotech, Inc.
11.11.1 Getein Biotech, Inc. Company Information
11.11.2 Getein Biotech, Inc. Infectious Disease Diagnostics Product Offered
11.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Getein Biotech, Inc. Main Business Overview
11.11.5 Getein Biotech, Inc. Latest Developments
11.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
11.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Company Information
11.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Main Business Overview
11.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Latest Developments
11.13 BGI Genomics Co.,Ltd.
11.13.1 BGI Genomics Co.,Ltd. Company Information
11.13.2 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 BGI Genomics Co.,Ltd. Main Business Overview
11.13.5 BGI Genomics Co.,Ltd. Latest Developments
11.14 Maccura Biotechnology Co.,Ltd.
11.14.1 Maccura Biotechnology Co.,Ltd. Company Information
11.14.2 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Maccura Biotechnology Co.,Ltd. Main Business Overview
11.14.5 Maccura Biotechnology Co.,Ltd. Latest Developments
11.15 Daan Gene
11.15.1 Daan Gene Company Information
11.15.2 Daan Gene Infectious Disease Diagnostics Product Offered
11.15.3 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Daan Gene Main Business Overview
11.15.5 Daan Gene Latest Developments
11.16 Beijing Strong Biotechnologies,Inc
11.16.1 Beijing Strong Biotechnologies,Inc Company Information
11.16.2 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product Offered
11.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Beijing Strong Biotechnologies,Inc Main Business Overview
11.16.5 Beijing Strong Biotechnologies,Inc Latest Developments
11.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
11.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Company Information
11.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Main Business Overview
11.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Latest Developments
11.18 Guangdong Hybribio Biotech Co.,Ltd.
11.18.1 Guangdong Hybribio Biotech Co.,Ltd. Company Information
11.18.2 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Guangdong Hybribio Biotech Co.,Ltd. Main Business Overview
11.18.5 Guangdong Hybribio Biotech Co.,Ltd. Latest Developments
11.19 Shanghai Runda Medical Technology Co.,Ltd.
11.19.1 Shanghai Runda Medical Technology Co.,Ltd. Company Information
11.19.2 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product Offered
11.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Shanghai Runda Medical Technology Co.,Ltd. Main Business Overview
11.19.5 Shanghai Runda Medical Technology Co.,Ltd. Latest Developments
11.20 Tellgen Corporation
11.20.1 Tellgen Corporation Company Information
11.20.2 Tellgen Corporation Infectious Disease Diagnostics Product Offered
11.20.3 Tellgen Corporation Infectious Disease Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Tellgen Corporation Main Business Overview
11.20.5 Tellgen Corporation Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
